Eli Lilly arthritis drug wins emergency approval for COVID-19 use
Published
Arthritis drug baricitinib is authorised for emergency use in combination remdesivir to treat COVID-19 patients.
Full ArticlePublished
Arthritis drug baricitinib is authorised for emergency use in combination remdesivir to treat COVID-19 patients.
Full ArticleWashington Post columnist Megan McArdle was anxious to tell readers that drug development in the pandemic has been a great..
Drug regulators in the US have given emergency use approval for Eli Lilly and Co's investigational monoclonal antibody therapy for..